Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature 454, 160-161 (10 July 2008) | doi:10.1038/454160a; Published online 9 July 2008
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
Assistant Professor of Medicine
- Massachusetts General Hospital
- Boston, MA
Environmental / Biotreatability Engineer
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
The contents of the syringe
Steven Salzberg1
- Steven Salzberg is at the Center for Bioinformatics and Computational Biology, 3125 Biomolecular Sciences Building, University of Maryland, College Park, Maryland 20742.
Abstract
The influenza vaccine failed this winter. Steven Salzberg suggests that future success relies on sharing data more widely and making the virus strain selection process more transparent.
During the past 50 years, the scientific community has studied the influenza virus in great detail, and has developed an effective vaccine that is administered widely each year. The vaccine contains isolates from each of the three strains commonly circulating in humans: H3N2, H1N1 and influenza B.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Know the enemyNature Biotechnology News and Views (01 Mar 2006)
Lessons from the 1918 influenzaNature Biotechnology News and Views (01 Apr 2007)
See all 3 matches for News And Views